Gambro acquires clinics in Portugal

Gambro acquires clinics in Portugal Stockholm, Sweden - Gambro AB (Stockholm Stock Exchange: GAMBaST, GAMBbST), a leading international medical technology and healthcare company, continues the expansion of the European dialysis clinics operation by acquiring clinics in Portugal. Gambro has acquired Medicassis in Lisbon consisting of two dialysis clinics with a total of 260 patients. The acquisition is made by the Portuguese subsidiary Gambro Lda., which thereby is strengthening its leading position on the Portuguese dialysis clinics market. During 1998 Gambro Lda. acquired Centro Hemodialysis do Lumiar in Lisbon with 160 patients. For further information please contact: Bengt Modéer, Senior Vice President, Corporate Communications, tel. +46-8-613 65 00, +46-70-513 65 33 Anna Augustson, European Investor Relations Manager, tel. +46-8-613 65 35, +46-70-513 65 34 Gambro is a global medical technology and healthcare company with leading positions in renal care - services and products - and blood component technology (BCT). Gambro is the second largest provider of kidney dialysis services in the world. Gambro treats about 41,500 patients in 568 clinics worldwide. Renal care products comprise dialyzers, dialysis machines, blood lines and dialysis fluid. BCT includes products for the separation and handling of blood components. The group, with revenue of approximately SEK 19 billion (USD 2.3 billion) has approximately 18,000 employees in some 40 countries. ------------------------------------------------------------ Please visit http://www.bit.se for further information The following files are available for download: http://www.bit.se/bitonline/1999/05/05/19990505BIT00080/bit0001.doc http://www.bit.se/bitonline/1999/05/05/19990505BIT00080/bit0002.pdf